View More Recent Stories

May 2, 2022 07:30AM Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting
May 2, 2022 07:30AM Decibel Therapeutics to Present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting
Mar 22, 2022 07:30AM Decibel Therapeutics to Participate in Upcoming Investor Conferences
Mar 22, 2022 07:30AM Decibel Therapeutics to Participate in Upcoming Investor Conferences
Mar 18, 2022 07:01AM Decibel Therapeutics (DBTX) Reports Q4 Earnings, Provides Corporate Update
Mar 18, 2022 07:00AM Decibel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
Mar 18, 2022 07:00AM Decibel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
Feb 10, 2022 04:30PM Decibel Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
Feb 10, 2022 04:30PM Decibel Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
Feb 9, 2022 06:22PM Decibel Therapeutics (DBTX) Issues Update on Progress of Lead Gene Therapy Product Candidate DB-OT, Presents Promising Preclinical Data Supporting Importance of Cell-Selective Transgene Expression
Feb 9, 2022 06:00PM Decibel Therapeutics Reports on Continued Progress of Lead Gene Therapy Product Candidate DB-OTO and Presents Promising Preclinical Data Supporting Importance of Cell-Selective Transgene Expression Ac
Feb 9, 2022 06:00PM Decibel Therapeutics Reports on Continued Progress of Lead Gene Therapy Product Candidate DB-OTO and Presents Promising Preclinical Data Supporting Importance of Cell-Selective Transgene Expression Ac
Jan 31, 2022 07:00AM Decibel Therapeutics to Present at the 45th Annual Association for Research in Otolaryngology (ARO) Meeting
Jan 31, 2022 07:00AM Decibel Therapeutics to Present at the 45th Annual Association for Research in Otolaryngology (ARO) Meeting
Jan 4, 2022 07:00AM Decibel Therapeutics to Present at the H.C. Wainwright BioConnect Conference
Jan 4, 2022 07:00AM Decibel Therapeutics to Present at the H.C. Wainwright BioConnect Conference
Dec 6, 2021 07:32AM Decibel Therapeutics (DBTX) Announces Appointments of Alison Finger, MBA and Saraswathy Nochur, Ph.D. to its Board of Directors; Christine Poon Steps Down from Board
Dec 6, 2021 07:30AM Decibel Therapeutics Announces Appointments of Alison Finger, MBA and Saraswathy Nochur, Ph.D. to its Board of Directors; Christine Poon Steps Down from Board
Dec 6, 2021 07:30AM Decibel Therapeutics Announces Appointments of Alison Finger, MBA and Saraswathy Nochur, Ph.D. to its Board of Directors; Christine Poon Steps Down from Board
Nov 22, 2021 07:33AM Decibel Therapeutics (DBTX) Extends Research Term under Strategic Collaboration with Regeneron; Will Receives $10M Extension Fee
Nov 22, 2021 07:30AM Decibel Therapeutics Announces Extension of Research Term under Strategic Collaboration with Regeneron to Discover and Develop Gene Therapies for Hearing Loss
Nov 22, 2021 07:30AM Decibel Therapeutics Announces Extension of Research Term under Strategic Collaboration with Regeneron to Discover and Develop Gene Therapies for Hearing Loss
Nov 10, 2021 07:30AM Decibel Therapeutics Reports Third Quarter 2021 Financial Results and Corporate Update
Nov 10, 2021 07:30AM Decibel Therapeutics Reports Third Quarter 2021 Financial Results and Corporate Update
Nov 8, 2021 07:00AM Decibel Therapeutics to Present at the Barclays Gene Editing & Gene Therapy Summit
Nov 8, 2021 07:00AM Decibel Therapeutics to Present at the Barclays Gene Editing & Gene Therapy Summit
Oct 20, 2021 07:30AM Decibel Therapeutics to Present at the Jefferies Gene Therapy/Editing Summit
Oct 20, 2021 07:30AM Decibel Therapeutics to Present at the Jefferies Gene Therapy/Editing Summit
Sep 30, 2021 05:42PM Decibel Therapeutics Announces Publication of Foundational Study of Noise-related Inner Ear Damage
Sep 30, 2021 05:42PM Decibel Therapeutics Announces Publication of Foundational Study of Noise-related Inner Ear Damage
Sep 9, 2021 07:31AM Decibel Therapeutics (DBTX) Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss
Sep 9, 2021 07:30AM Decibel Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss
Sep 9, 2021 07:30AM Decibel Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss
Sep 2, 2021 07:30AM Decibel Therapeutics to Present at Upcoming Investor Conferences
Sep 2, 2021 07:30AM Decibel Therapeutics to Present at Upcoming Investor Conferences
Aug 18, 2021 07:30AM Decibel Therapeutics Appoints Cynthia Hu as Chief Legal Officer and Corporate Secretary
Aug 18, 2021 07:30AM Decibel Therapeutics Appoints Cynthia Hu as Chief Legal Officer and Corporate Secretary
Aug 10, 2021 07:30AM Decibel Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Update
Aug 10, 2021 07:30AM Decibel Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Update
Jun 2, 2021 08:33AM Decibel Therapeutics (DBTX) Appoints Dr. William H. Carson as Chairman of the Board of Directors
Jun 2, 2021 08:30AM Decibel Therapeutics Appoints Dr. William H. Carson as Chairman of the Board of Directors
Jun 2, 2021 08:30AM Decibel Therapeutics Appoints Dr. William H. Carson as Chairman of the Board of Directors
May 24, 2021 04:15PM Decibel Therapeutics Expands World-Class Scientific Advisory Board
May 24, 2021 04:15PM Decibel Therapeutics Expands World-Class Scientific Advisory Board
View More Recent Stories